881 related articles for article (PubMed ID: 11959983)
1. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
Park SY; Ryu J; Lee W
Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
[TBL] [Abstract][Full Text] [Related]
3. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
Arias EB; Kim J; Cartee GD
Diabetes; 2004 Apr; 53(4):921-30. PubMed ID: 15047606
[TBL] [Abstract][Full Text] [Related]
4. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome.
Lee JE; Park JH; Moon PG; Baek MC
Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262
[TBL] [Abstract][Full Text] [Related]
5. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
Haltiwanger RS; Grove K; Philipsberg GA
J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
[TBL] [Abstract][Full Text] [Related]
6. Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance.
Macauley MS; Bubb AK; Martinez-Fleites C; Davies GJ; Vocadlo DJ
J Biol Chem; 2008 Dec; 283(50):34687-95. PubMed ID: 18842583
[TBL] [Abstract][Full Text] [Related]
7. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
8. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
9. Proteomics and PUGNAcity will overcome questioning of insulin resistance induction by nonselective inhibition of O-GlcNAcase.
Dehennaut V; Lefebvre T
Proteomics; 2013 Oct; 13(20):2944-6. PubMed ID: 23983178
[TBL] [Abstract][Full Text] [Related]
10. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
11. Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes.
Whelan SA; Dias WB; Thiruneelakantapillai L; Lane MD; Hart GW
J Biol Chem; 2010 Feb; 285(8):5204-11. PubMed ID: 20018868
[TBL] [Abstract][Full Text] [Related]
12. Relationship between protein O-linked glycosylation and insulin-stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate.
Arias EB; Cartee GD
Acta Physiol Scand; 2005 Mar; 183(3):281-9. PubMed ID: 15743388
[TBL] [Abstract][Full Text] [Related]
13. Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes.
Robinson KA; Ball LE; Buse MG
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E884-90. PubMed ID: 17122093
[TBL] [Abstract][Full Text] [Related]
14. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
Johnson B; Opimba M; Bernier J
Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
[TBL] [Abstract][Full Text] [Related]
15. Defective Akt activation is associated with glucose- but not glucosamine-induced insulin resistance.
Nelson BA; Robinson KA; Buse MG
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E497-506. PubMed ID: 11832350
[TBL] [Abstract][Full Text] [Related]
16. Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells.
Matthews JA; Belof JL; Acevedo-Duncan M; Potter RL
Mol Cell Biochem; 2007 Apr; 298(1-2):109-23. PubMed ID: 17136481
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes.
Macauley MS; He Y; Gloster TM; Stubbs KA; Davies GJ; Vocadlo DJ
Chem Biol; 2010 Sep; 17(9):937-48. PubMed ID: 20851343
[TBL] [Abstract][Full Text] [Related]
18. Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.
Gandy JC; Rountree AE; Bijur GN
FEBS Lett; 2006 May; 580(13):3051-8. PubMed ID: 16684529
[TBL] [Abstract][Full Text] [Related]
19. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
[TBL] [Abstract][Full Text] [Related]
20. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
